SPOTLIGHT -
Biogen Submits Protocol for Phase 4 Aducanumab Study, FDA AdComm's Board Doesn't Recommend AMX0035 Approval, Intensive SBP Increases Cerebral Blood Flow
Neurology News Network for the week ending April 2, 2022. [WATCH TIME: 3 minutes]
NeurologyLive® Friday 5 — April 1, 2022
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending April 1, 2022.
Give the Gift of Life: Donate Blood
The virtual MJH Life Sciences Sleeves Up Blood Drive, put on by NeurologyLive®'s parent company, will be held from March 31 through April 30, 2022.
This Week on NeurologyLive® — March 28, 2022
Here's what is coming soon to NeurologyLive®.
NeurologyLive® Friday 5 — March 25, 2022
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending March 25, 2022.
This Week on NeurologyLive® — March 21, 2022
Initial Phase 4 RESPOND Results, Omaveloxolone Continues to Perform in FA, Wearable Sensors Safe for FSHD
Neurology News Network for the week ending March 19, 2022.
NeurologyLive® Friday 5 — March 18, 2022
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending March 18, 2022.
This Week on NeurologyLive® — March 14, 2022
Cladribine Shows No Increased COVID-19 Risks, Migraine Preventative Preferences, Benefits of Mobile Stroke Units
Neurology News Network for the week ending March 12, 2022. [WATCH TIME: 4 minutes]
NeurologyLive® Friday 5 — March 11, 2022
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending March 11, 2022.
This Week on NeurologyLive® — March 7, 2022
Resistance Training Effective for Pompe Disease, PPMS Similar to SPMS, Factors Associated With Modified Atkins Diet
Neurology News Network for the week ending March 4, 2022. [WATCH TIME: 4 minutes]
NeurologyLive® Friday 5 — March 4, 2022
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending March 4, 2022.
This Week on NeurologyLive® — February 28, 2022
RapidAI Detects ICH With High Accuracy, Fenfluramine Plasma Levels Low, Nerivio More Effective With Behavioral Intervention
Neurology News Network for the week ending February 26, 2022. [WATCH TIME: 3 minutes]
NeurologyLive® Friday 5 — February 25, 2022
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending February 25, 2022.
This Week on NeurologyLive® — February 21, 2022
Carbidopa Levodopa Fractional Tablet Launched, Tenecteplase Shows Benefit After 24-Hour Window, Biogen Issues Response to CMS on Aducanumab
Neurology News Network for the week ending February 19, 2022. [WATCH TIME: 3 minutes]
NeurologyLive® Friday 5 — February 18, 2022
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending February 18, 2022.
Massachussets General Hospital: Institutional Perspectives in Neurology, Chaired by Eric Kawiter, MD, MSc
Chaired by Eric Klawiter, MD, MSc, the presentations also feature Mass General and Brigham and Women's experts Tanuja Chitnis, MD; Kristin Galetta, MD; and Michael Levy, MD, PhD. [WATCH TIME: 1 hour, 26 minutes]
This Week on NeurologyLive® — February 14, 2022
Non-Whites Underrepresented in MS DMT Trials, Stroke Risk in PD-Related Genes, Phase 2a ADv Study Initiated
Neurology News Network for the week ending February 12, 2022. [WATCH TIME: 3 minutes]
NeurologyLive® Friday 5 — February 11, 2022
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending February 11, 2022.
This Week on NeurologyLive® — February 7, 2022
Optimal Teneceplase Dosing for Elders Identified, BMI Associated With Worse Cognitive Decline, Slight Improvements in Migraine Preventive Use
Neurology News Network for the week ending February 5, 2022. [WATCH TIME: 4 minutes]
NeurologyLive® Friday 5 — February 4, 2022
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending February 4, 2022.
Child Neurology Foundation Summer 2022 Scholarships
Parkinson & Movement Disorder (PMD) Alliance Announces the Release of Sleep Disturbance in Patients with Parkinson’s Disease, A Continuing Medical Education (CME) Course for Advanced Practice Providers
This Week on NeurologyLive® — January 31, 2022
